The Chinese Pharma industry is rapidly upgrading its capabilities, moving from being a supplier of basic molecules and generics to becoming a major force in the development of innovative, molecular-targeted treatments and gene-based therapies. The Swiss Chinese Life Sciences Forum 2018 organised by BaselArea.swiss, the Fachhochschule Nordwestschweiz and the Swiss Chinese Chamber of Commerce and hosted by Novartis offers insights into key players in the Chinese Pharma landscape and identifies opportunities for greater collaboration between Swiss and Chinese Pharma.
Key themes:
- Innovation in the Chinese Pharma Industry
- Internationalisation – Chinese Pharma companies go global
- China’s recent regulatory reform and the impact on innovation
- Swiss Pharma in China – the case of Novartis
- Collaboration between European and Chinese Life Sciences companies
For details and registration visit www.swiss-chinese-life-sciences-forum.ch
Programm Details
13:30
Welcome Addresses
- Matthias Leuenberger, Country President Switzerland, Novartis
- Thomas Christ, Acting President SCCC
13:45
Novartis Shanghai Campus Live Transmission
Live Stream
Dr. Larry Zhang, VP, Head Public Affairs & CSR, Novartis China
14:05
Keynote 1 – "Challenges and opportunities of creating a global pharmaceutical company in China."
John Oyler, CEO and Founder of BeiGene
14:25
Keynote 2 – "Luye Pharma Group’s Internationalization: Strategy and Experiences."
Sammy Jiang, VP Luye Pharma Group
14:45
Keynote 3 – "Regulatory reform in China: How to rapidly bring innovative drugs to market."
Dr. Ruyi He, Chief Scientist at the Center for Drug Evaluation at the China Food and Drug Administration (CFDA)
15:30
Keynote 4 - "Going East – China as the frontier for new Innovation"
Nigel Sheail, Global Head M&A and BD&L, Novartis International AG
15:50
Keynote 5 – Swiss-Chinese Pharma Deal: Challenges and Learnings
Martin Rohrbach, Partner, Head of Life Sciences, KPMG Switzerland
16:10
Panel discussion
Keynote speakers + Michael Frizberg, CEO, CMAB International
17:00
Closing summary & thanks
17:10
Apéro
18:30
End
